Spontaneous remission of anti-Ma associated paraneoplastic mesodiencephalic and brainstem encephalitis

H. Prüß(Universität Hamburg), Klaus‐Peter Wandinger(Universität Hamburg), Hans Gelderblom(Leiden University Medical Center), R. Zschenderlein, D. L. Munz(Charité - Universitätsmedizin Berlin), Georg Böhner(Humboldt-Universität zu Berlin), Raymond Voltz(University of Cologne)
Journal of Neurology
January 19, 2008
10.1007/s00415-008-0573-8
Cited by 10

Related Papers

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
|The Lancet|2012|1.4k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k